FDA U.S. Agent Pricing in 2026: What Each Tier Buys and What It Excludes

Introduction

FDA U.S. Agent pricing is the private cost of maintaining a qualified U.S. contact for a foreign facility. The annual fee may buy little more than designation and message forwarding, or it may include registration work, renewal tracking, communication triage, and inspection coordination.

The headline market spans roughly $99 to $2,500 per year, but that range mixes fundamentally different services. Current published base-agent prices among the providers reviewed here cluster much more tightly around $295 to $300 per facility; prices move higher when providers add FSVP responsibility, product-level filings, technical submissions, or regulatory consulting.

As of August 27, 2026, four of the six reviewed providers publish at least one current U.S. Agent or registration-and-agent price: FDA Entry Point, FDABasics, Axentra, and Orionex. Registrar Corp and FDAImports do not publish a current base U.S. Agent price on their reviewed service pages. The most useful transparency test is therefore not merely whether a number appears, but whether the buyer can also see what remains excluded.

The 2026 pricing landscape by service tier

Price bands reflect annual or annualized provider fees, excluding applicable FDA government user fees.

The middle tier is where the buyer generally stops paying only for a name on a form and starts paying for work that gets done. The important qualification is that “work” must be defined: communication handling and renewal tracking are not the same as paying for every registration, product listing, shipment filing, or regulatory response.

Current published prices from six FDA U.S. Agent providers

The evidence does not support saying that most of these six providers hide every base price: four publish a current figure and two do not. FDA Entry Point’s distinction is the depth of itemization—its public schedule separates the annual agent fee from food registration, Prior Notice, label review, listings, and technical submissions rather than presenting only one starting number.

Provider fees are not always FDA fees

FDA charges no fee for initial food facility registration, renewal, updates, or cancellation. FDA also charges no fee to submit a cosmetic facility registration or product listing under MoCRA. Fees charged for performing those filings are therefore private professional-service fees, not government registration charges. FDA food facility fee guidance and FDA MoCRA registration guidance establish those distinctions.

Medical devices are the important exception. It is not accurate to say that FDA charges no fee for device establishment registration. The FY 2026 annual establishment registration fee is $11,423 through September 30, 2026. It increases to $13,785 for FY 2027 beginning October 1, 2026. That government fee is separate from any U.S. Agent or registration-service fee. FDA medical-device user fees

A registration certificate is usually a provider document

FDA does not issue food, MoCRA cosmetics, or medical-device registration certificates. Providers may supply a confirmation document for importers, marketplaces, distributors, or internal records, but it should be labeled as provider-issued documentation rather than FDA certification or approval. FDA specifically explains this for cosmetics registration and medical-device certificates.

The recurring line items buyers should require in every quote

What an annual U.S. Agent fee does—and does not—buy

The base fee should cover the standing agent relationship

• Designation of a qualified U.S.-based person or business in the applicable FDA registration.

• Availability for routine FDA communications and inspection-scheduling inquiries.

• Prompt forwarding of notices to a named client contact.

• Confirmation that the provider has agreed to act as agent where the FDA system requires confirmation.

• Continuity for the contracted term and a defined renewal process.

The base fee usually does not cover the entire compliance workload

• FSVP importer or FSVP Agent responsibility.

• Prior Notice filings for each food shipment or article.

• Facility registration unless the package expressly includes it.

• Product listings, NDC work, SPL/XML submissions, or GUDID/UDI records.

• Label, ingredient, claim, website, or advertising review.

• Responses to warning letters, detention defense, import-alert removal, recalls, or legal representation.

• FDA government user fees, including the medical-device establishment fee.

A useful buying rule is to treat every verb as separately priced until the quote says otherwise. “Receive” does not necessarily mean “analyze,” “forward” does not mean “prepare a response,” and “registration support” does not always mean the provider owns every renewal, amendment, and product-level update.

Contract terms and exit cost belong in total cost of ownership

The cheapest first-year quote can become expensive if it auto-renews, forfeits prepaid fees, charges for every facility, or makes the provider change difficult. Buyers should evaluate the cost to leave with the same care as the cost to start.

What a clean transfer requires

• A confirmed end date for the outgoing service and start date for the incoming agent.

• Access to the owner/operator account, registration number, FEI, DUNS/UFI, submission history, and current product records.

• An update in the correct FDA registration system rather than an informal email between providers.

• Incoming-agent confirmation where required. For medical devices, a proposed agent that does not confirm within 10 business days must be replaced.

• Written confirmation that the old provider will not cancel, deactivate, or alter records before the new designation is active.

• Clear ownership of future renewals, amendments, product listings, and open FDA communications.

FDA permits a foreign facility to change its U.S. Agent, but the private contract determines whether prepaid service fees are refunded. The regulatory transfer and the commercial exit are therefore two separate events. FDA medical-device U.S. Agent confirmation process

The false economy of a $99 mailbox agent

The annual difference between a $99 agent and a $295 full-service relationship is $196, or about $16.33 per month. Compared with a $150 agent, the difference is $145, or about $12.08 per month.

That means the cheaper provider produces a real saving only while the operational cost of its exclusions remains below $145–$196 per year. One missed renewal, late FDA response, unnecessary broker escalation, storage invoice, re-filing exercise, or management fire drill can erase the entire difference. A detention does not need to become a catastrophic loss for the low-tier saving to fail its own break-even test.

FDA generally provides 10 business days to respond to a detention, with notices commonly allowing up to 20 calendar days for weekends, holidays, and delivery time. Failure to respond can lead to refusal, after which the goods must generally be exported or destroyed under supervision within 90 days. A responsive agent cannot guarantee admissibility, but a passive inbox can make a time-sensitive problem worse. FDA detention and hearing process and FDA import-refusal requirements

The minimum tier is defensible when

• The foreign manufacturer already has an experienced regulatory team that owns every registration, listing, renewal, and FDA response.

• The buyer needs only a qualified U.S. contact and has confirmed the provider’s availability, escalation process, and forwarding time.

• The facility has simple records, few changes, limited shipment activity, and no need for Prior Notice, FSVP, label, SPL, or GUDID support.

• The contract is short, cancellable, and does not restrict account access or switching.

The minimum tier is usually the wrong tradeoff when

• A founder or operations lead has no dedicated U.S. regulatory hire.

• The business is making its first commercial imports or managing seasonal and multi-product food shipments.

• The company expects the agent to receive, explain, and help coordinate responses to FDA notices rather than merely forward them.

• Renewal discipline, product listings, label claims, SPL, GUDID/UDI, or MoCRA obligations are already stretching the internal team.

• The facility makes drugs or medical devices, where technical filings, inspection readiness, and per-product revenue raise the cost of an operational miss.

• The business is already detained, subject to an import alert, or replacing an agent that resigned or lapsed.

Where FDA Entry Point fits in the pricing landscape

FDA Entry Point sits in the operational middle tier at $295 per facility per year. Its strongest pricing distinction is not that it is the cheapest provider; it is that the base fee and common adjacent services are itemized publicly. A food exporter can see the agent fee, food facility registration, Prior Notice, and food label review prices without entering a quote funnel.

FDA Entry Point is the best fit when

• The buyer wants active FDA communication handling and renewal tracking at a published annual price.

• A small or mid-size foreign manufacturer needs registration, listings, labels, or submission support available under the same relationship, while retaining a clear view of which work is separately billed.

• The business operates across food, cosmetics, drugs, or medical devices and wants one compliance partner rather than a different agent for each vertical.

• Transparent Prior Notice and label-review charges matter because shipment volume and SKU count affect the real annual budget.

FDA Entry Point is not a fit when

• The buyer wants only the lowest possible name-on-form service and already has the staff to perform every adjacent compliance task.

• The primary requirement is to outsource the legal role of FSVP importer, customs brokerage, litigation, or specialized import-alert defense rather than U.S. Agent and registration continuity.

Buyers evaluating the operating model can review how FDA Entry Point handles U.S. Agent and compliance work. Food importers should separately confirm whether they need an FSVP Importer, a U.S. Agent, or both.

A quote-comparison checklist for foreign manufacturers

1. Normalize the unit. Confirm whether the fee applies per facility, legal entity, FDA registration, product category, or year.

2. Separate standing coverage from filing work. Identify which registrations, renewals, listings, and amendments are included.

3. Price shipment activity. Calculate Prior Notice costs using expected shipments and product lines, not only the advertised per-filing price.

4. Define communication handling. Require response times and distinguish forwarding from regulatory analysis or response preparation.

5. Identify every government fee. Keep FDA user fees separate from the provider’s professional charges.

6. Clarify documentation. Determine whether any certificate is provider-issued and whether submission confirmations are included.

7. Review the renewal mechanism. Check the renewal date, automatic billing, price-change notice, and who owns the filing calendar.

8. Calculate exit cost. Include non-refundable prepaid fees, cancellation charges, incoming-agent onboarding, record recovery, and internal transition time.

9. Protect account access. The manufacturer should retain the credentials and records needed to replace the provider without a compliance gap.

Frequently asked questions

How much does it cost to hire an FDA U.S. Agent in 2026?

A base FDA U.S. Agent generally costs a few hundred dollars per facility per year, with four reviewed published offers clustering at $295–$300. The wider $99–$2,500 market range reflects different scopes: the low end may provide designation and forwarding, while the high end can include registration, FSVP functions, supplier review, technical filings, or consulting. FDA Entry Point publishes $295 annually, while FDABasics publishes $299 for one year or $250 per year on a two-year agreement. FDA Entry Point pricing and FDABasics pricing

Why do some FDA U.S. Agent services hide their pricing behind a quote form?

Quote-gated pricing usually signals a sales-led or scope-dependent model rather than one standardized service. Product category, facility count, shipment volume, listing volume, FDA correspondence, and desired consulting can materially change the work. That may be reasonable for complex engagements, but it prevents a buyer from comparing the base fee and exclusions before speaking with sales. Registrar Corp’s current agent page presents configurable services without visible prices, while FDAImports routes current service inquiries through contact forms. Registrar Corp U.S. Agent service and FDAImports

Is a cheap FDA U.S. Agent worth the risk?

A minimum-price agent can be reasonable when an experienced internal regulatory team owns every filing, deadline, and FDA response. It is usually a poor trade for a first-time exporter or a company without dedicated regulatory staff. The difference between $99 and $295 is only $196 annually. FDA can move from detention to refusal if a response is not submitted within the specified period, making communication speed and clear ownership more important than a small annual saving. FDA detention guidance

Does the annual U.S. Agent fee include food registration, Prior Notice, label review, or FSVP?

Not automatically; each service must be confirmed separately. Some providers include food facility registration with the agent fee, while FDA Entry Point itemizes it at $249. Prior Notice is typically priced per filing or shipment, label review per product, and FSVP as a separate annual or project engagement. FSVP can cost substantially more because it involves supplier verification responsibilities rather than merely serving as FDA’s communication contact. US Imports FSVP pricing

Does FDA charge a fee for facility registration?

FDA charges no registration fee for food facilities or MoCRA cosmetic facility registration and product listing. Medical-device establishments are different: the FY 2026 annual registration fee is $11,423 through September 30, 2026, rising to $13,785 on October 1, 2026 for FY 2027. Provider fees for completing filings are separate from these government charges. FDA food registration guidance, FDA cosmetics guidance, and FDA device fees

Can a foreign manufacturer switch FDA U.S. Agents mid-term?

Yes, but the FDA record update and the private contract exit must both be completed. The incoming agent may need to confirm the designation, and the outgoing agreement determines whether prepaid fees are refunded or a cancellation charge applies. FDABasics, for example, publishes a $250 administrative deduction for qualifying pre-work cancellations and no refund after work begins. Before switching, secure registration credentials, submission records, open correspondence, and written confirmation of the transfer date. FDABasics cancellation terms and FDA agent-change mechanics

References

• FDA: Food facility registration fees and private registrars

• FDA: MoCRA cosmetic facility registration and product listing guidance

• FDA: FY 2026 and FY 2027 medical-device user fees

• FDA: Detention and hearing process

• FDA: Import refusals

• FDA Entry Point: Published pricing

• FDABasics: U.S. Agent pricing

• Axentra: 2026 U.S. Agent pricing

• Orionex: Registration and U.S. Agent packages

• Registrar Corp: U.S. Agent service

• Registrar Corp: Prior Notice Express pricing

• FDAImports: Current regulatory services